, Hong Kong
177 views

1 in 2 Hong Kongers said they have ‘no spare money’ for insurance

This is despite 80% saying they understood the importance of insurance.

Having ‘no spare money' was the top reason 50% of Hong Kongers for not buying critical illness, life, and personal accident insurance, a survey by the digital insurer Blue revealed.

This was followed by 22% who thought these insurance products were too complicated to understand.

Meanwhile, over 80% of the survey respondents understood the importance of critical illness, life and personal accident protection. In addition, 71% of the respondents showed their interest in buying a 3-in-1 insurance plan that covers critical illness, life and personal accident protection all at once, mainly due to “no need to manage policies separately” (47%), followed by it being “cheaper than purchasing three policies individually” (36%) and that “the plan is more flexible” (32%).

The survey also revealed that for households with a monthly income of less than HK$20k ($2.55k, the median of monthly spending on insurance could reach HK$2,100 ($267.65) if they own life, critical illness and personal accident insurance.
.
The survey, commissioned with ESDlife, was conducted in May 2022, covering 352 Hong Kong residents aged 25 to 54.
 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.